A national conversation with an unparalleled look into the leading minds that are shaping today's public health decisions, economic policies, regulatory and governance, and the emergence of a new normal.
Site
RSS
Apple
DonnĂŠes mises Ă jour le 29/08/2026
Classements rĂŠcents
Dernières positions dans les classements Apple Podcasts et Spotify.
Liens partagĂŠs entre ĂŠpisodes et podcasts
Liens prĂŠsents dans les descriptions d'ĂŠpisodes et autres podcasts les utilisant ĂŠgalement.
Antibodies, Vaccines & Baby Season: An RSV Prevention Masterclass with Dr. Zain Chagla PART 2
Saison 1 ¡ Ăpisode 32
mercredi 19 aoÝt 2026 ⢠DurÊe 23:25
Episode Description
RSV prevention now comes with options. Great newsâuntil you have to decide who gets what, when, and how to make sure it actually happens. đŚ đ
In Part 2 of our conversation, infectious disease specialist Dr. Zain Chagla returns to the FindMyVaccine Podcast to take RSV prevention from the guideline page to the front lines.
First up: timing really is everything. A baby born during RSV season may be best protected before leaving hospital. A baby born in July? Not so fast. Dr. Chagla explains why the goal isnât simply to immunize at the earliest opportunityâitâs to line up the protection window with the infantâs period of greatest RSV exposure. Think less âASAPâ and more âright place, right season.â
Then comes the big practical question: maternal vaccination or infant monoclonal antibody?
We unpack gestational timing, the important two-week window before delivery, infant risk factors, family preference, local program availabilityâand why this conversation belongs in the birth plan, not as a surprise item at discharge.
With multiple monoclonal antibody options now in the toolkit, we also ask: how do you actually choose one?
Dr. Chagla walks through dosing, age and season indications, access, inventory and workflow considerations.
And because guidelines always sound easier until an actual patient walks in, we put Zain through a special rapid-fire RSV rounds. âĄ
Four babies. Four different scenarios. No multiple-choice answers.
A healthy baby born in July.
A newborn delivered nine days after maternal RSV vaccination.
A premature infant.
A 14-month-old with chronic lung disease heading into season two.
Dr. Chagla offers a practical way to explain risk without frightening parents or overselling protection.
Finally, we finish with a Monday-morning checklist for clinicians. Because ultimately, the best RSV strategy isnât necessarily the fanciest one.
Â
Learning Objectives
By the end of this episode, listeners will be able to:
Apply RSV seasonality to prevention timing, distinguishing the approach for infants born during versus outside peak RSV activity.
Compare maternal RSV vaccination and infant monoclonal antibody strategies, considering gestational timing, infant risk, family preference and local program availability.
Recognize situations where monoclonal antibody protection may still be appropriate, including insufficient time between maternal vaccination and delivery or increased infant risk.
Evaluate practical factors involved in monoclonal antibody selection, including authorized indications, dosing, age, workflow, accessibility and second-season considerations.
Apply RSV prevention recommendations to common real-world cases, including healthy infants, premature newborns and medically high-risk children.
Counsel parents about RSV risk in a balanced and understandable way, setting realistic expectations about what preventive interventions canâand cannotâdo.
Identify practical system changes that can improve RSV prevention,
#FindMyVaccine ď¸ #RSV #RSVPrevention  #MonoclonalAntibodies #MaternalVaccination #PassiveImmunization #Pediatrics #InfectiousDiseases  #NACI #PublicHealth #ClinicalPractice #VaccineEducation #NewbornHealth #CanadianHealthcare
SUPPORTED BY AN IME GRANT FROM MERCK.
Â
Â
Â
About Dr. Zain Chagla
HAMILTON, ONÂ
Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Josephâs Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.Â
Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.Â
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
Â
Antibodies, Vaccines & Baby Season: An RSV Prevention Masterclass with Dr. Zain Chagla
Saison 1 ¡ Ăpisode 31
lundi 17 aoÝt 2026 ⢠DurÊe 26:24
Episode Description
RSV prevention has entered its âmore options, more questionsâ era. đśđŚ
In Part 1, infectious disease specialist Dr. Zain Chagla returns to the FindMyVaccine Podcast to help sort through what Canadian clinicians actually need to know about protecting infants from RSV.
First up: who is really at risk? Spoilerâthe answer is not just premature or medically fragile babies. Dr. Chagla explains why otherwise healthy, full-term infants can still end up hospitalized with RSV, why those first few months of life matter so much, and how to communicate that risk to families without turning counselling into a horror movie.
We then tackle the updated NACI guidance and the increasingly important choice between maternal vaccination and long-acting monoclonal antibodies. Who should receive what? When does maternal vaccination leave an infant needing additional protection? And which higher-risk babies deserve a particularly proactive plan?
Then comes the immunologyâminus the painful lecture.
Dr. Chagla explains why monoclonal antibodies are not vaccines, how passive immunization essentially gives infants ready-made RSV-fighting antibodies, and why newer long-acting options have changed the game from repeated injections to protection that can potentially cover much of an RSV season.
And because percentages alone rarely tell the whole story, we dig into the evidence: pivotal trials, hospitalization outcomes, absolute risk reduction, high-risk infant data, and why comparing one RSV monoclonal antibody trial directly with another can get scientifically⌠messy.
Bottom line: RSV prevention is no longer simply about knowing that options exist. It is about knowing which option, for which infant, at which time.
Class is officially in session. đď¸
Learning Objectives
By the end of this episode, listeners will be able to:
Dr. Zain Chagla
BC Premier David Eby and the Provincial Healthcare Rethink
Saison 1 ¡ Ăpisode 30
vendredi 13 fÊvrier 2026 ⢠DurÊe 36:34
â Â What happens when you put BCâs biggest healthcare pain points on the tableâand agree that âweâve always done it this wayâ isnât a strategy?
đ¨ď¸  In this special episode, BC Premier David Eby, joins us for a sit down candid, practical conversation about the realities of modernizing healthcare in British Columbiaâstarting with the unglamorous but high-impact stuff: cutting administrative duplication across health authorities, centralizing procurement and shared services, and creating clearer accountability so problems get fixed faster.
 đď¸We explore what frontline clinicians want: a tighter feedback loop where ideas from pharmacists, nurses, physicians, and allied health donât disappear into a âsuggestion boxâ black hole and unpack the real promiseâand real limitsâof AI integration into day to day healthcare across BC: where itâs already helping, and what it takes to scale innovation safely with privacy protections.
 đď¸BC Cancerâand the growing operational pressure of rising diagnoses, delayed access, and complex patient journeys. Premier Eby shares whatâs underway and tackles a question that may be on the minds of HCPs and caregivers: do we need to revisit BCâs 10-year cancer plan to match todayâs system realities and  explore practical system fixes like patient navigators om the BC Cancer care pathway.
 đď¸Youâll also hear a frank discussion on expanding pharmacy-delivered care, the pressures and possibilities of minor ailments and contraceptive services, and how new reimbursement models may unlock pharmacist impact beyond the walls of a community pharmacy.
 đď¸This episode arguably tackles some of the toughest files facing the Ministry of Health: rare-disease drug reimbursement decisions, transparency and modernization in PharmaCare, balancing urgent access with fair pricing, and what meaningful accountability looks like when care delivery goes wrong.We also unpack regulation and oversight through the Health Professions Act: is it enough to protect the public and drive system-level learning, or do we need additional tools in the middle ground between individual college complaints and full-blown litigation?
ABOUT BC Premier Hon. David Eby, KC
Policing, Policy & Public Health: A Candid Conversation with Vancouver Police Chief Adam Palmer (PART 2)
Saison 1 ¡ Ăpisode 29
jeudi 1 mai 2025 ⢠DurÊe 29:01
đPolicing, Policy & Public Health: A Candid Conversation with Chief Adam Palmer
We sit down with Adam Palmer, outgoing Chief of the Vancouver Police Department (VPD) and newly appointed RCMP Assistant Commissioner, for a frank, highly practical look at where law enforcement, social policy, mental health, and substance use collideâwhatâs working, what isnât, and how health + public safety might be able to row in the same direction.
Audience. a clinician, policymaker, or community leaderÂ
What we dive into with our guest:Â
Decriminalizationâlessons learned: why BC police initially supported a health-first path, what didn't work (public order + weak care pathways), and what guardrails are needed for real-world success.
Integrated care pathways: inside Vancouverâs policeânurse partnerships (Car 87/88, Assertive Outreach, psych nurses in the command centre), with cohorts showing impact on police calls and ED visits.
Targeting harm, not illness: how âTask Force Barrageâ a city-aligned surge focused on violent offenders, traffickers, criminal networks alongside city sanitation and bylaw action-while reaffirming you canât arrest your way out of social problems.
Policy priorities for federal leaders: Â bail reform for chronic violent offenders and scaling compassionate/secure care capacity for the small, high-risk subset chronically dangerous to themselves or others.
AI readiness for health + public safety: Â patient safety implications, and practical risk controls.
How HCPs can help today: shared data pathways, and clinic-to-street feedback loops that improve triage and outcomes.
Â
Chief Palmer argues for:
Stronger three-level government alignment
Thoughtful bail reform for chronic violent offenders
Scaled âcompassionate mandatory / secure careâ capacity for the small but high-risk subset that may be dangerous to themselves/others
Policing, Policy & Public Health: A Candid Conversation with Vancouver Police Chief Adam Palmer (PART 1)
Saison 1 ¡ Ăpisode 28
mardi 29 avril 2025 ⢠DurÊe 32:14
đPolicing, Policy & Public Health: A Candid Conversation with Chief Adam Palmer
We sit down with Adam Palmer, outgoing Chief of the Vancouver Police Department (VPD) and newly appointed RCMP Assistant Commissioner, for a frank, highly practical look at where law enforcement, social policy, mental health, and substance use collideâwhatâs working, what isnât, and how health + public safety might be able to row in the same direction.
Audience. a clinician, policymaker, or community leaderÂ
What we dive into with our guest:Â
Decriminalizationâlessons learned: why BC police initially supported a health-first path, what didn't work (public order + weak care pathways), and what guardrails are needed for real-world success.
Integrated care pathways: inside Vancouverâs policeânurse partnerships (Car 87/88, Assertive Outreach, psych nurses in the command centre), with cohorts showing impact on police calls and ED visits.
Targeting harm, not illness: how âTask Force Barrageâ a city-aligned surge focused on violent offenders, traffickers, criminal networks alongside city sanitation and bylaw action-while reaffirming you canât arrest your way out of social problems.
Policy priorities for federal leaders: Â bail reform for chronic violent offenders and scaling compassionate/secure care capacity for the small, high-risk subset chronically dangerous to themselves or others.
AI readiness for health + public safety: Â patient safety implications, and practical risk controls.
How HCPs can help today: shared data pathways, and clinic-to-street feedback loops that improve triage and outcomes.
Â
Chief Palmer argues for:
Stronger three-level government alignment
Thoughtful bail reform for chronic violent offenders
Scaled âcompassionate mandatory / secure careâ capacity for the small but high-risk subset that may be dangerous to themselves/others
CIC 2024: NACI, Real World Evidence and Pharmacoeconomic Modeling with Dr. Jesse Papenburg
Saison 1 ¡ Ăpisode 27
mardi 17 dÊcembre 2024 ⢠DurÊe 14:17
đď¸ CIC 2024: NACI, Real World Evidence and  Pharmacoeconomic Modeling with Dr. Jesse Papenburg đď¸
We sit down with dynamic public health leader and clinician scientist Dr. Jesse Papenburgâa member of the National Advisory Committee on Immunization (NACI) and the Quebec Immunization Committee, where he leads the influenza and RSV working groups, respectively, Â and the voice behind some of the latest vaccine recommendations đ.
We unpack the science behind high-dose, adjuvanted, and recombinant influenza vaccines đ§ŹđŠş, specifically tailored for adults 65+. Discover how these specialized vaccines offer enhanced protection by boosting immune responses where it counts the most đđŞ.
Dr. Jesse Papenburg also sheds light on the groundbreaking RSV vaccines designed to shield older adults from severe respiratory illnesses đ¤§đĄď¸
With behind the scenes insights into how cost-effectiveness, real-world efficacy, and economic modeling factor behind NACI's recommendations đđĄ, this episode delivers both the technical deep dive and the human touch that brings public health to life â¤ď¸.
And for a refreshing twist, learn about Jesse Papenburg's off-duty passion đđĽ.
Learning Objectives:
Decipher the Vaccine Jargon: Understand why high-dose, adjuvanted, and recombinant influenza vaccines are revolutionizing protection for adults 65+ and 75+ đľď¸ââď¸đ.
RSV Revealed: Gain insight into the new RSV vaccines for seniors, how they reduce the risk of severe respiratory infections, and why they're becoming a critical tool in our public health arsenal đĄď¸đ.
Risk Factors & Real Talk: Explore how age, comorbidities, and living environments like long-term care facilities amplify risksâand why personalized vaccine strategies are essential in todayâs healthcare landscape đĽđ.
Tech Talk + Public Health: Delve into the emerging role of AI and predictive modeling in shaping future vaccination policies, offering a fresh perspective on how data-driven insights are changing the game đ¤đ
About Dr. Jesse Papenburg
CIC 2024: Predictive AI and Precision Modeling with Dr. Caroline Quach
Saison 1 ¡ Ăpisode 26
mardi 3 dÊcembre 2024 ⢠DurÊe 13:11
đđĽđEver heard of a sourdough geek who also happens to be a rockstar vaccine expert? Join host đ¤ Dr. Carolyn Quash on the Find My Vaccine Podcast as she kneads out the details with immunization guruÂ
đ Dr. Caroline Quachâfresh from Quebec đ and fresh out of flour! From sprinkling dough across her kitchen (sorry, husband!) to sprinkling wisdom on immunocompromised patient care đĽđĄ, Dr. Quach dishes on how precision vaccinology đĄ, AI-driven modeling đ¤, and big-data insights đ are stirring up a brand-new recipe for public health guidance. Get ready to rise to the occasionâand maybe rise some bread on the side! đđĽ
Learning Objectives đŻ
Sourdough & Science đĽđŹ: Understand how baking bread (yes, really!) parallels the trial-and-error approach in developing vaccination recommendations.
Immunocompromised Insights đđ¤: Learn the biggest challenges (and breakthroughs) in vaccinating special patient populationsâespecially those under biologics or CAR T-cell therapies.
Modeling & More đ¤đ: Discover how in silico trials, predictive modeling, and AI might shape tomorrowâs vaccination schedules.
Policy in Action đâď¸: Grasp the role of NACI in translating groundbreaking research into real-world immunization guidance.
Donât miss this chance â° to raise your knowledge, feed your curiosity, and find the perfect recipe for innovative vaccine strategies! Tune in now, and letâs get kneading! đĽđď¸đ
Â
About Dr. Caroline Quach
Dr. Caroline Quach is a Professor in the Departments of Microbiology, Infectious Diseases & Immunology and of Pediatrics at University of Montreal. She is an adjunct Professor in the Department of Epidemiology, Biostatistics & Occupational Health at McGill University and a scientific collaborator at the School of Public Health at UniversitĂŠ Libre de Bruxelles (ULB) in Brussels. She is the physician in charge of Infection Prevention and control at CHU Sainte-Justine where she also works as a pediatric infectious diseases specialist and medical microbiologist. Dr. Quach is a clinician-scientist, supported by the Fonds de Recherche QuĂŠbec â SantĂŠ (FRQS, chercheure boursière de mĂŠrite) and was recently awarded the Canada Research Chair, Tier 1 in Infection Prevention and Control. Her research interests are in Infection Prevention: both healthcare-associated and vaccine-preventable diseases.
COVID-19 Fall Update: A New Variant and the Big Update on Strain Selection with Dr.Zain Chagla
Saison 1 ¡ Ăpisode 25
lundi 9 septembre 2024 ⢠DurÊe 37:23
đď¸FindMyVaccine is back with infectious diseases physician, Dr. Zain Chagla, who joins us from Toronto in studio.
As we head into Fall 2024, it's not just the leaves changing-we cover the latest updates on COVID-19, new variants, new boosters, and new messaging we head into respiratory season. đŚ
In this episode, we cut through the noise and dive into what you need to know.
â Why is this surge happening again? We'll look at the data from this past summer's outbreaks and discuss why it's crucial to stay on top of this evolving situation.
đĄď¸ Booster blues? Vaccine uptake is still low among at-risk populations, and there's a new booster in town. But how do you communicate that effectively to patients without sounding like a broken recordâor worse, adding to the confusion?
đĄNavigating patient conversations around booster recommendations đ and why the message has shifted. Get practical tips for identifying high-risk patients and translating NACI recommendations into action. It's not just about age; it's about timing, awareness, and making sure your patients understand why the next dose matters.
đ Plus, we discuss how to prioritize COVID vs. flu vaccines.Â
đ§ Tune in for the latest on COVID, and more, with expert insights and a touch of humor.
Key Concepts:
COVID Surge Alert: Hospitalizations and test positivity are up again đŚ đ
Vaccine Timing: Why itâs crucial to get your COVID shot now, with flu and RSV lurking around the corner. đŻđ
Cross-Neutralization Explained: How the new COVID variants differ and why updated vaccines still provide protection. đ§ŹđĄď¸
COVID Therapeutics: Paxlovid effectiveness in the context of new variantsđââď¸đ
Patient Conversations: Strategies for helping patients understand their risks and prioritize getting vaccinated. đŁď¸đŠââď¸
Â
Dr. Zain Chagla
The Six Most Urgent Questions about COVID and the Journey Ahead: Part 2
Saison 1 ¡ Ăpisode 24
lundi 12 juin 2023 ⢠DurÊe 17:34
âśď¸đ§đď¸PART 2! Tools to use on the frontline and tips to engage your patients in 60 seconds or less. We untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with đđŤ.Alan Kaplan and Dr.Marla Shapiro who break down all  you need to know.
âď¸âď¸We take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?
âď¸âď¸We delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?
âď¸âď¸We examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.Â
âď¸âď¸We're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?
âď¸âď¸Keeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.Â
Letâs dive in!Â
Dr.Alan KaplanÂ
Dr.Alan Kaplan, MD,  CCFP(EM), CPC(HC) is a  family Physician practicing in York Region, Ontario, Canada.
Regional Primary Care Lead, Central Regional Cancer Program
Chairperson of the Family Physician Airways Group of Canada
Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada () and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.
The Six Most Urgent Questions about COVID and the Journey Ahead: Part 1
Saison 1 ¡ Ăpisode 23
lundi 5 juin 2023 ⢠DurÊe 22:03
âśď¸đ§đď¸Today we untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with đđŤ.Alan Kaplan and Dr.Marla Shapiro who break down all  you need to know.
âď¸âď¸We take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?
âď¸âď¸We delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?
âď¸âď¸We examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.Â
âď¸âď¸We're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?
âď¸âď¸Keeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.Â
Letâs dive in!Â
Dr.Alan KaplanÂ
Dr.Alan Kaplan, MD,  CCFP(EM), CPC(HC) is a  family Physician practicing in York Region, Ontario, Canada.
Regional Primary Care Lead, Central Regional Cancer Program
Chairperson of the Family Physician Airways Group of Canada
Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada () and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.
Describe the clinical burden of RSV in infants and explain why severe disease can occur even in previously healthy, full-term babies.
Interpret updated Canadian RSV prevention guidance, including the respective roles of maternal vaccination and infant monoclonal antibodies.
Identify infants who may warrant a more proactive monoclonal antibody strategy, including those with prematurity, cardiopulmonary disease, immunodeficiency, other medical risk factors, or barriers to timely healthcare access.
Explain the difference between vaccination and passive immunization, including how long-acting monoclonal antibodies provide immediate protection against RSV.
Translate RSV clinical trial results into practical clinical meaning, including relative efficacy, absolute reductions in hospitalization, and important limitations when comparing evidence across trials.
Apply seasonality and local RSV surveillance when considering the timing of infant prevention strategies.
#FindMyVaccine  #RSV #RSVPrevention #InfantHealth #MonoclonalAntibodies #MaternalVaccination #PassiveImmunization #NACI #Pediatrics #InfectiousDiseases  #PublicHealth #CanadianHealthcare
Supported by an IME Grant from Merck
Â
Â
Â
Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Josephâs Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.Â
Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.Â
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
Â
Â
Â
âśď¸If youâre a frontline clinician, health leader, or policy-watcher who wants less theatre and more solutionsâthis oneâs for you.
đĄđĄÂ In this episode, we look at:
The role of a new provincial âshared servicesâ model and health authority optimization
What a province-wide AI strategy needs before it touches routine prescribing workflows
Where pharmacist scope is headingâand what may be missing to make it sustainable
Why rare-disease drug coverage decisions feel like a black box (and how to fix that) and Pharmacare
The case for better patient navigation during their cancer care journey
Reach us at:  info@leadersofpharmacy.com or info@myvaccinepodcast.com
Â
Our hearts are with everyone affectedâalong with their families, friends, and the Tumbler Ridge, B.C. communityâcoping  with an unimaginable loss during this heartbreaking time.Â
Â
David Eby is a determined problem-solver who has spent a lifetime taking on powerful interests to get things done for people.
As Premier of B.C., David is taking action on the biggest challenges facing British Columbians. Heâs standing up to wealthy speculators and investors to deliver more homes middle-class people can afford. Heâs working to ease the pressure of everyday costs, from reducing car insurance and childcare bills to making prescription birth control free. And heâs strengthening health care by building hospitals and hiring more family doctors.
Under Davidâs leadership, B.C. is an economic leader in Canadaâcreating tens of thousands of good-paying jobs to deliver the lowest unemployment rate and some of the fastest growing wages in the country.
Alongside John Horgan, David got the influence of big money out of B.C.âs elections and cracked down on money laundering in casinos and real estate. He took on opioid manufacturers and delivered a first-of-its-kind settlement to hold corporations accountable for the overdose crisis. He stood up to the trial lawyers and removed legal costs from ICBC process to reduce car insurance rates by an average of $500 a year for drivers. He even went after organized crimeâclosing down Hells Angels clubhouses and targeting the proceeds of crime to make our communities safer.
Before being elected as the MLA for Vancouver-Point Grey, David was an award-winning lawyer and legal scholar. He started his career on Vancouverâs Downtown Eastside, defending the homes of low-income people from big developers and slum lords. His work on human rights and democratic freedoms has been recognized by the United Nations Association in Canada and the B.C. Human Rights Coalition.
David was an adjunct professor of law at the University of British Columbia, president of the HIV-AIDS Legal Network, and served on the Vancouver Foundationâs Health and Social Development Committee. From 2009 to 2013, David ran the B.C. Civil Liberties Association as executive director.
David was raised in a suburban middle-class home. The son of a schoolteacher and a lawyer, he remains grounded in the values he grew up with â commitment to family, community, and helping the less fortunate. He is now a proud husband and father with three children of his own, Ezra, Iva, and baby Gwen. He loves playing with his kids, practising yoga and hanging out with his wife Cailey, a family doctor in Vancouver.
As B.C.âs 37th premier, David is working hard to build a better, stronger future for everyone. Because he believes his kids and all British Columbians deserve the same opportunities to build a good life.Â
Continued integration with healthcare as AI risks and city growth accelerate.
Â
Â
Guest Note: Adam Palmer served as VPD Chief (2015â2025) and has just announced his new role as Assistant Commissioner with the RCMP, attached to National HQ (Ottawa) while remaining based in BC.
Â
ABOUT CHIEF CONSTABLE ADAM PALMER
CHIEF CONSTABLE ADAM PALMER took command as the 31st Chief Constable of the Vancouver Police Department on May 6th, 2015. Chief Palmer was born and raised in the Vancouver area.
Prior to joining the Vancouver Police, he studied Business Administration at Simon Fraser University and worked as a correctional officer. Chief Palmer began his career with the VPD in 1987 and since that time has worked in a variety of operational, investigative and administrative areas. He previously managed a long-term review of policing operations in Vancouver that resulted in improved efficiencies, the optimization of existing resources and significant increases in sworn and civilian police staffing. He was a Venue Commander during the 2010 Winter Olympics where he oversaw the security of figure skating and speed skating events.
Chief Palmer was President of the Canadian Association of Chiefs of Police (CACP) from 2018-2020 and served on the CACP Board of Directors as Past President until August 2022. He served on the Board of Directors for the International Association of Chiefs of Police (IACP) from 2018 to 2020. In January 2019, Chief Palmer was elected to and currently serves on the Board of Directors for the Major Cities Chief Association (MCCA), which represents the largest police departments in the United States and Canada. Chief Palmer also serves as Chair of the Combined Forces Special Enforcement Unit (CFSEU) Board of Directors, is a member of the National Executive Committee for the Criminal Intelligence Service of Canada (CISC), the Metro Vancouver Transit Police Board of Directors and the Criminology Advisory Committee for Kwantlen Polytechnic University. He is also a former Board member of the Canadian Police Knowledge Network (CPKN). In 2023, Chief Palmer became a Board Member for the Police Executive Research Forum (PERF), a police research and policy organization.
In 2009, Chief Palmer was invested as a Member of the Order of Merit of the Police Forces and in 2017 was promoted to the rank of Officer of the Order of Merit of the Police Forces. In 2020, in recognition of the national and international scope of his service and leadership, the Governor General of Canada advanced Chief Palmer to the highest rank within the Order of Merit of the Police Forces, the rank of Commander.
In 2021, Chief Palmer received the Major Cities Chiefs Association Leadership Award, the first Canadian police officer to receive this honour. In 2022, he received the CACPâs Recognition Award for developing a national mentorship program for police executive leaders. As Past President of the CACP, Chief Palmer was chosen to receive the King Charles III Coronation Medal in 2024. He is the recipient of nine Vancouver Police Department Commendations and is a former VPD Police Officer of the Year.
Continued integration with healthcare as AI risks and city growth accelerate.
Â
Â
Guest Note: Adam Palmer served as VPD Chief (2015â2025) and has just announced his new role as Assistant Commissioner with the RCMP, attached to National HQ (Ottawa) while remaining based in BC.
Â
ABOUT CHIEF CONSTABLE ADAM PALMER
CHIEF CONSTABLE ADAM PALMER took command as the 31st Chief Constable of the Vancouver Police Department on May 6th, 2015. Chief Palmer was born and raised in the Vancouver area.
Prior to joining the Vancouver Police, he studied Business Administration at Simon Fraser University and worked as a correctional officer. Chief Palmer began his career with the VPD in 1987 and since that time has worked in a variety of operational, investigative and administrative areas. He previously managed a long-term review of policing operations in Vancouver that resulted in improved efficiencies, the optimization of existing resources and significant increases in sworn and civilian police staffing. He was a Venue Commander during the 2010 Winter Olympics where he oversaw the security of figure skating and speed skating events.
Chief Palmer was President of the Canadian Association of Chiefs of Police (CACP) from 2018-2020 and served on the CACP Board of Directors as Past President until August 2022. He served on the Board of Directors for the International Association of Chiefs of Police (IACP) from 2018 to 2020. In January 2019, Chief Palmer was elected to and currently serves on the Board of Directors for the Major Cities Chief Association (MCCA), which represents the largest police departments in the United States and Canada. Chief Palmer also serves as Chair of the Combined Forces Special Enforcement Unit (CFSEU) Board of Directors, is a member of the National Executive Committee for the Criminal Intelligence Service of Canada (CISC), the Metro Vancouver Transit Police Board of Directors and the Criminology Advisory Committee for Kwantlen Polytechnic University. He is also a former Board member of the Canadian Police Knowledge Network (CPKN). In 2023, Chief Palmer became a Board Member for the Police Executive Research Forum (PERF), a police research and policy organization.
In 2009, Chief Palmer was invested as a Member of the Order of Merit of the Police Forces and in 2017 was promoted to the rank of Officer of the Order of Merit of the Police Forces. In 2020, in recognition of the national and international scope of his service and leadership, the Governor General of Canada advanced Chief Palmer to the highest rank within the Order of Merit of the Police Forces, the rank of Commander.
In 2021, Chief Palmer received the Major Cities Chiefs Association Leadership Award, the first Canadian police officer to receive this honour. In 2022, he received the CACPâs Recognition Award for developing a national mentorship program for police executive leaders. As Past President of the CACP, Chief Palmer was chosen to receive the King Charles III Coronation Medal in 2024. He is the recipient of nine Vancouver Police Department Commendations and is a former VPD Police Officer of the Year.
NACI's Art of Decision Making:  Behind the scenes insights into how cost-effectiveness, real-world efficacy, and economic modeling factor behind NACI's recommendations đđĄ
Whether you're a healthcare provider seeking the latest evidence-based updates or a public health policy buff, this episode promises a perfect blend of scientific rigor, practical insights, and a dash of fun! đ§â¨
Â
Dr. Jesse Papenburg practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Childrenâs Hospital of the McGill University Health Centre.
After his specialty training, Dr. Papenburg completed a research fellowship on the molecular virology of RNA respiratory viruses at Laval University and an MSc in epidemiology at McGill. As a clinician scientist, he studies the epidemiology of viral respiratory infections. Dr. Papenburg is a member of the National Advisory Committee on Immunization and the Quebec Immunization Committee where he leads the influenza and RSV working groups, respectively. Â
Dr. Quach is the former Chair of the National Advisory Committee on Immunization (NACI )from the Public Health Agency of Canada. She is a former president from the Association for Medical Microbiology and Infectious Diseases (AMMI) Canada (2014-2016). She was named Fellow of the Canadian Academy of Health Sciences and of the Society for Healthcare Epidemiology of America. Dr. Quach was selected as one of the 2019 most Powerful Women in Canada (2019 Top 100 Award Winner in the Manulife Science and Technology category). Â
Â
Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Josephâs Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.Â
Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.Â
As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.
Alanâs other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group
Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.
Â
Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, DFCM, University of Toronto
Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.
Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.
Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.
Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this countryâs highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation. Â
Alanâs other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group
Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.
Â
Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, DFCM, University of Toronto
Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.
Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.
Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.
Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this countryâs highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation. Â
Â
Â
Podcasts Similaires BasĂŠes sur le Contenu
DÊcouvrez des podcasts liÊes à Findmyvaccine Podcast. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similaritÊs sont calculÊes grâce à des donnÊes tangibles, pas d'extrapolations !
